INO On Track, MITO All Powered Up, TGTX Braces For Busy Year, COVID-19 Update

Today's Daily Dose brings you news about an update on Inovio's COVID-19 DNA Vaccine trials, Ocular Therapeutix's preliminary fourth-quarter revenue, Stealth BioTherapeutics' receipt of Rare Pediatric Disease designation for Elamipretide and near-term catalysts of TG Therapeutics.

from RTT - Biotech https://ift.tt/2Tp2KKt
via IFTTT